• Ionomycin free acid: Calcium Ionophore Workflows

  2026-09-19

  Build reproducible calcium ion transport, live-cell signaling, and oocyte activation assays with a controlled ionophore workflow. The guide also shows how to use calcium perturbation as an exploratory complement to the FAISL–FAK proteolysis model in triple-negative breast cancer research.

• Polybrene: Practical Guide to Viral Transduction

  2026-09-18

  Learn how Polybrene improves viral attachment, supports difficult lipid-mediated DNA transfection, and fits into controlled cell-engineering workflows. Practical titration, handling, and troubleshooting guidance helps balance delivery efficiency against cell-specific toxicity while clarifying what the FBXO22 degrader literature does—and does not—show.

• CGP 55845 hydrochloride: GABAB Assay Workflows

  2026-09-18

  Use CGP 55845 hydrochloride to separate GABAB receptor signaling from astrocytic GAT-3 activity in controlled neural assays. This workflow combines presynaptic pharmacology, electrophysiology, neurotransmitter release measurements, and troubleshooting guidance for more interpretable synaptic transmission research.

• EdU Flow Cytometry Assay Kits (Cy5) for S-Phase

  2026-09-17

  Measure active DNA synthesis without harsh denaturation using a bright Cy5 click-chemistry workflow. This guide translates the DCPS–epithelial proliferation findings in diabetic foot-ulcer research into practical assay design, controls, and troubleshooting strategies.

• Moxidectin: From Anthelmintic to Assay Modulator

  2026-09-17

  Moxidectin is best known as a macrocyclic lactone anthelmintic, but emerging evidence reveals a precise assay opportunity in polyene-based antifungal research. This article explains the ergosterol-centered mechanism, experimental decision points, formulation considerations, and the limits of translating veterinary antiparasitic evidence into oral candidiasis studies.

• Oleic Acid Assays: Reliable Lipid Models

  2026-09-16

  A scenario-driven guide to using Oleic Acid (SKU C4977) in viability, proliferation, cytotoxicity, and hepatocyte lipid-loading workflows. It connects formulation, solvent handling, pathway interpretation, and vendor selection to reproducible lipid metabolism research.

• Honokiol, Paraptosis, and MAPK Signaling in APL

  2026-09-16

  This study identifies honokiol-induced paraptosis-like death as a nonapoptotic response in NB4 acute promyelocytic leukemia cells and links it to proteasome impairment, endoplasmic reticulum stress, mTOR activity, and MAPK signaling. Its pharmacologic dissection provides a useful framework for interpreting MEK/ERK pathway inhibition, while also highlighting the limits of transferring findings from leukemia cells to neuronal or inflammatory models.

• BAP1 Regulation of Disulfidptosis

  2026-09-15

  A 2024 Oncogenesis study identifies BAP1 as a suppressor of glucose starvation-induced disulfidptosis through repression of SLC7A11-dependent cystine uptake and preservation of NADPH-linked reducing capacity. The findings clarify why the same BAP1–SLC7A11 axis can promote ferroptosis in one metabolic context while limiting disulfidptosis in another.

• Saracatinib (AZD0530): From Src Biology to Translation

  2026-09-15

  Saracatinib (AZD0530) offers a mechanistically grounded way to interrogate Src family kinase and Abl signaling across cancer models. This thought-leadership guide connects pathway biology, assay design, xenograft interpretation, and a carefully bounded neuroscience bridge to help translational researchers turn kinase inhibition into more informative experimental decisions.

• I-BET-762: BET Inhibitor Workflow & Applications

  2026-09-14

  I-BET-762 supports both inflammation-focused transcriptional studies and cancer ferroptosis workflows through selective BET bromodomain inhibition. This practical guide connects assay design, solvent handling, ROS/FSP1 readouts, and troubleshooting to published combination data.

• WP1066, JAK2/STAT3 Inhibitor: Assay Guide

  2026-09-14

  This scenario-based guide explains how WP1066, JAK2/STAT3 inhibitor, cell-permeable (SKU A4140), can support reproducible cell viability, proliferation, and pathway-inhibition assays. It connects dose selection, solvent controls, mechanistic readouts, and supplier evaluation with evidence from cancer models and recent JAK2/STAT3 research.

• EdU Flow Cytometry Assay Kits (Cy5): Workflow

  2026-09-13

  EdU Flow Cytometry Assay Kits (Cy5) support flow-cytometric measurement of S-phase DNA synthesis without the harsh DNA-denaturation step used in many BrdU workflows. This guide covers reagent handling, CuAAC detection, controls, and troubleshooting; the assay should be validated separately for systems with restricted EdU incorporation, copper-sensitive downstream steps, or Cy5 spectral conflicts.

• Chloramphenicol and the New Logic of Plasmid AMR

  2026-09-12

  Chloramphenicol is more than a selection antibiotic: its mechanism and workflow utility offer translational researchers a disciplined way to study plasmid maintenance, resistance-gene localization, and horizontal transfer. This article connects molecular biology practice with recent carbapenem-resistant Enterobacter cloacae findings while defining the limits of that cross-domain interpretation.

• TRAP-1 Reactivates p53Y220C Through Induced Proximity

  2026-09-11

  The bioRxiv preprint reports TRAP-1, a small-molecule chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4. This interaction rapidly increases p21 and other p53 target genes and suppresses growth in p53Y220C-expressing pancreatic cancer cell lines, providing evidence that transcriptional reactivation can be achieved without relying solely on mutant-protein stabilization.

• Angiotensin 1/2 (5-7): RAS Research Guide

  2026-09-11

  Angiotensin 1/2 (5-7) is the H2N-Ile-His-Pro-OH peptide, a short angiotensin fragment supplied for renin-angiotensin system research. Product specifications support controlled biochemical workflows, while a 2025 study provides in vitro evidence that this fragment can enhance SARS-CoV-2 spike–AXL binding.

8023 records 1/535 page Next 12345 下5页 Last page